MYD88 and diffuse large B-cell lymphoma: Among them, the so-called MCD subtype included 71 out of 574 DLBCL cases and was characterized by high frequency of MYD88 or CD79B mutations (82% of cases), with double concomitant mutations in 42% of cases.